Androgen composition for treating an opthalmic condition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9119772
SERIAL NO

13357779

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALLERGAN INC2525 DUPONT DRIVE IRVINE CA 92612

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Giyanani, Jaya Irvine, US 15 61
Gore, Anuradha V Irvine, US 44 220
Pujara, Chetan P Irvine, US 57 340
Salameh, Adnan K Irvine, US 20 118
Trogden, John T Villa Park, US 40 1213

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00